Health economic evaluation aims at providing information on the efficiency of interventions.
Since the 1980s, there have been major developments in the field, especially in terms of …

This systematic study aims at analyzing the differences between the approach of the
European healthcare systems to the pharmaceutical market and the American one. This …

The world is facing a continuous increase in medical costs. Due to the surge in disease
prevalence, medical science is becoming more sensitive to the economic impact of …

Purpose During the last five decades drug and therapeutics committees (DTCs), have
evolved from mainly hospital-based groups of experts in pharmacotherapy and drug …

Despite increasing interest in health economic evaluation, investigations have shown limited
use by micro (clinical) level decision-makers. A considerable amount of health decisions …

Objectives To investigate which factors and criteria are used in priority setting of
pharmaceuticals, in what contexts health economic evaluations are used, and barriers to the …

With rapid increases in healthcare spending over recent years, health economic evaluation
might be thought to be increasing in importance to decision-makers. Such evaluations are …

Reinventing the Pharmacy and Therapeutics Committee - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

A hospital is a supplier of healthcare services and is therefore an economic unit. It uses
factors of production to produce healthcare services. The typical microeconomic theory on …

In this chapter, the international literature on affordable medicine prices and corresponding
pricing policies is reviewed. A broad range of sources is used: the academic peer-reviewed …